Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VivoRx
Santa Monica / Los Angeles area, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
VivoRx was an inactive biopharmaceutical company focused on developing encapsulated islet cell therapies for insulin-dependent diabetes, reaching Phase 1/2 clinical trials. It was a wholly-owned subsidiary of Abraxis BioScience and is now defunct.
- Therapeutic areas
- Endocrinology
- Modalities
- Cell therapyBiologic delivery systems
- Industry
- Biotech
02
Partnerships
Mylan Laboratories (exclusive license to market the company's diabetes control technology during its development phase)
Beyond the preview
Go deeper on VivoRx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VivoRx.